Pankaj Kumar | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Pankaj Kumar | Immunology and Microbiology | Best 

Pankaj Kumar,The Ohio State University,United States

Pankaj Kumar is a Ph.D. researcher at Ohio State University. His research focuses on cancer biology, immunotherapy, and molecular mechanisms. He has published several papers and received awards for his work.

Publication Profile

orcid

Education

Pankaj Kumar completed his Ph.D. in Molecular and Cancer Biology from CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) Hyderabad, India (2014-2021). He received his M.S. in Biotechnology from Babasaheb Bhimrao Ambedkar University (BBAU), Lucknow, India (2011-2013) and B.S. in Biotechnology from Chhatrapati Shahu Ji Maharaj University (CSJMU), Kanpur, India (2008-2011).

Experience

Pankaj Kumar worked as a Postdoctoral Research Scholar at Ohio State University (February 2021-present). He was a Research Fellow (Ph.D.) at CSIR-Centre for Cellular and Molecular Biology, Hyderabad (August 2014-October 2021).

Awards And Honors

Pankaj Kumar received the Keystone Symposia travel award (2019), Carl Storm International Diversity (CSID) fellowship (2018), International Travel grant from ICMR-India (2018), CSIR-NET (Junior/Senior Research Fellowship-2015), and DBT-JRF (Junior Research Fellowship-2014).

Research Focus

Pankaj Kumar’s research focuses on cancer biology, immunotherapy, molecular mechanisms, and drug resistance. His work explores the molecular basis of cancer, multidrug resistance, tumor metastasis, and cancer immunotherapy.

Publications

  1. Hsp90 facilitates acquired drug resistance of tumor cells through cholesterol modulation however independent of tumor progression 📄
  2. The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis 📄
  3. Altered molecular pathways decides the treatment outcome of Hsp90 inhibitors against breast cancer cells 📄
  4. Targeting squalene epoxidase interrupts homologous recombination via the ER stress response and promotes radiotherapy efficacy 📄
  5. Heat shock transcription factor HSF2 modulates the autophagy response through the BTG2-SOD2 axis 📄
  6. Effect Of OSU-ERβ-12, A Carborane-based ERβ-selective Agonist, On Hepatic Fibrosis And NASH 📄
  7. The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling 📄